Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion

American Journal of Physiology - Endocrinology and Metabolism

Volumn 294, Issue 6, 2008, Pages

  Toth, Michael J ^a   Cooper, Brian C ^b   Pratley, Richard E ^b   Mari, Andrea ^b   Matthews, Dwight E ^b   Casson, Peter R ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; C PEPTIDE; ESTRADIOL; ESTRONE; INSULIN; LEUPRORELIN; PLACEBO; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; ADIPONECTIN; ADIPONECTIN, HUMAN; C REACTIVE PROTEIN; ESTROGEN; GLUCOSE; GONADORELIN; LEPTIN;

ADULT; ARTICLE; BODY FAT; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; NORMAL HUMAN; OVARY FUNCTION; PRIORITY JOURNAL; ABDOMINAL FAT; BLOOD; BODY COMPOSITION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; KINETICS; METABOLISM; OVARY; OXYGEN CONSUMPTION; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SECRETION;

ABDOMINAL FAT; ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; C-REACTIVE PROTEIN; ESTROGENS; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INSULIN; KINETICS; LEPTIN; LEUPROLIDE; OVARY; OXYGEN CONSUMPTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47549085955     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00789.2007     Document Type: Article

References (59)

1. Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, Basu A, Vittone JL, Klee GG, Puneet A, Jensen MD, Toffolo G, Cobelli C, Rizza RA. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action and clearance. Diabetes 52: 1738-1748, 2003.
2. Buffenstein R, Poppitt SD, McDevitt RM, Prentice AM. Food intake and the menstrual cycle: a retrospective analysis, with implications for appetite research. Physiol Behav 58: 1067-1077, 1995.
3. Cagnacci A, Paolletti AM, Arangino S, Melis GB, Volpe A. Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism. Hum Repro 14: 893-897, 1999.
4. Cagnacci A, Soldani R, Carriero PL, Paolettin AM, Fioretti P, Melis GB. Effects of low doses of trandermal 17beta-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocr Metab 74: 1396-1400, 1992.
5. Chauhan S, Collens K, Kruger M, Diamond MP. Effect of gonadotropin-releasing -hormone hypogonadism on insulin action as assessed by hyperglycemic clamp studies in men. Fertil Steril 81: 1092-1098, 2004.
6. Chu MC, Cosper P, Nakhuda GS, Lobo RA. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil Steril 86: 1669-1675, 2006.
7. Cooper BC, Sites CK, Casson PR, Toth MJ. Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. Fertil Steril 87: 1131-1138, 2007.
8. Cooper BC, Sites CK, Fairhurst PA, Toth MJ. Evidence against a role for ovarian hormones in the regulation of blood flow. Fertil Steril 86: 440-447, 2006.
9. Cornier MA, Bergman BC, Bessesen DH. The effect of short-term overfeeding on insulin action in lean and reduced-obese individuals. Metab Clin Exp 55: 1207-1214, 2006.
10. Cuccinelli F, Paparella P, Soranna L, Barini A, Cinque B, Mancuso S, Lanzone A. Differential effect of transdermal estrogen plus progestagen replacement on insulin metabolism in postmenopasual women: relation to their insulinemic secretion. Eur J Endocrinol 140: 215-223, 1999.
11. Diamond MP, Grainger D, Diamond MC, Sherwin RS, DeFronzo RA. Effects of methyltestosterone on insulin secretion and sensitivity in women. J Clin Endocr Metab 83: 4420-4425, 1998.
12. Diamond MP, Jacob R, Connolly-Diamond M, DeFronzo RA. Glucose metabolism during the menstrual cycle: assessment with the euglycemic, hyperinsulinemic clamp. J Reprod Med 38: 417-421, 1993.
13. Diamond MP, Simonson DC, DeFronzo RA. Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril 52: 204-208, 1989.
14. Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol Cell Physiol 274: C1645-C1652, 1998.
15. Dumesic DA, Nielsen MF, Abbott DH, Eisner JR, Nair KS, Rizza RA. Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women. Fertil Steril 72: 458-466, 1999.
16. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resisance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174, 1989.
17. Duncan AC, Lyall H, Roberts RN, Petrie JR, Perera MJ, Monaghan S, Hart DM, Connell JMC, Lumsden MA. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenpausal women. J Clin Endocr Metab 84: 2402-2407, 1999.
18. Evans EM, Van Pelt RE, Binder EF, Williams DB, Ehsani AA, Kohrt WM. Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition in older women. J Appl Physiol 90: 2033-2040, 2001.
19. Fong Y, Matthews DE, He W, Marano MA, Moldawer LL, Lowry SF. Whole body and splanchnic leucine, phenylalanine and glucose kinetics during endotoxemia in humans. Am J Physiol Regul Integr Comp Physiol 266: R419-R425, 1994.
20. Gavrilla A, Chan JL, Yiannakouris N, Kontagianni M, Miller LC, Orlova C, Mantzoros CS. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocr Metab 88: 4823-4831, 2003.
21. Godsland IF, Gangar K, Walton C, Cust MP, Whitehead MI, Wynn V, Stevenson JC. Insulin resistance, secretion, and elimination in post-menopausal women receving oral or transdermal hormone replacement therapy. Metabolism 42: 846-853, 1993.
22. Grainger D, Thornton K, Rossi G, Connoly-Diamond M, DeFronzo RA, Sherwin RS, Diamond MP. Influence of basal androgen levels in euandrogenic women on glucose homeostasis. Fertil Steril 58: 1113-1118, 1992.
23. Haisch M, Fukagawa NK, Matthews DE. Oxidation of glutamine by the splanchnic bed in humans. Am J Physiol Endocrinol Metab 278: E593-E602, 2000.
24. Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol 47: 101-106, 1997.
25. Iozzo P, Beck-Nielsen H, Laasko M, Smith U, Yki-Jarvinen H, Ferrannini E. Independent influence of age on basal insulin secretion in nondiabetic humans. J Clin Endocr Metab 84: 863-868, 1999.
26. Kanaya AM, Herrington D, Vittinghoff E, Lin K, Grady D, Bittner V, Cauley JA, Barrett-Connor E. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. Ann Intern Med 138: 1-9, 2003.
27. Kumagai S, Holmang A, Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 149: 91-97, 1993.
28. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Bogardus C. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocr Metab 62: 922-927, 1986.
29. Lindheim SR, Duffy DM, Kojima T, Vijod MA, Stanczyk FZ, Lobo RA. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 62: 1176-1180, 1994.
30. Lindheim SR, presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 60: 664-667, 1993.
31. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV; Women's Health initiative Investigators. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47: 1175-1187, 2004.
32. Melanson KJ, Saltzman E, Russell RG, Roberts SB. Postabsorptive and postprandial energy expenditure and substrate oxidation do not change during the menstrual cycle in young women. J Nutr 126: 2531-2538, 1996.
33. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281: 2654-2660, 2006.
34. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51: 2734-2741, 2002.
35. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM, Bremner WJ. Testosterone administration supresses adiponectin levels in men. J Androl 26: 85-92, 2005.
36. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu MJ, Knopps A, Xiang AH, Utschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279: 12152-12162, 2004.
37. Proudler AJ, Felton CV, Stevenson JC. Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women. Clin Sci 83: 489-494, 1992.
38. Pulido JME, Salazar MA. Changes in insulin sensitivity, secretion and glucose effectiveness during the menstrual cycle. Arch Med Res 30: 19-22, 1999.
39. Richard D. Effects of ovarian hormones on energy balance and brown adipose tissue thermogenesis. Am J Physiol Regul Integr Comp Physiol 250: R245-R249, 1986.
40. Rincon J, Holmang A, Wahlstrom EO, Lonnroth P, Bjorntorp P, Zierath JR, Wallberg-Henriksson H. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45: 615-621, 1996.
41. Rossi R, Origliani G, Modena MG. Transdermal 17-beta-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women. Diabetes Care 27: 645-649, 2004.
42. Ryan AS, Nicklas BJ, Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 25: 127-133, 2002.
43. Sites CK, L'Hommedieu GD, Toth MJ, Brochu M, Cooper BC, Fairhurst PA. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90: 2701-2707, 2005.
44. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17beta to human plasma protein at body temperature. J Steroid Biochem 26: 801-810, 1982.
45. Thornton KL, DeFronzo RA, Sherwin RS, Diamond MP. Micronized estradiol and progesterone: effects on carbohydrate metabolism in reproductive-age women. J Soc Gynecol Invest 2: 643-652, 1995.
46. Toth EL, Suthijumroon A, Crockford PM, Ryan EA. Insulin action does not change during the menstrual cycle in normal women. J Clin Endocr Metab 64: 74-80, 1987.
47. Toth MJ, Eltabbakh GH, Sites CK, Poehlman ET. Effect of menopausal status on insulin-stimulated glucose disposal. Diabetes Care 23: 801-806, 2000.
48. Toth MJ, Sites CK, Cefalu WT, Matthews DE, Poehlman ET. Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women. Am J Physiol Endocrinol Metab 281: E113-E121, 2001.
49. Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes 24: 226-231, 2000.
50. Valdes C, Elkind-Hirsch K. Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocr Metab 72: 642-646, 1991.
51. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from c-peptide levels: comparison of individual and standard kinetic paramters for c-peptide clearance. Diabetes 41: 368-377, 1992.
52. 13C abundance of carbohydrates. Rapid Commun Mass Spectrom 15: 496-500, 2001.
53. van Genugten RE, Utzschneider KM, Tong J, Gerchman F, Zraika S, Udayasankar J, Boyko EJ, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes 55: 3529-3535, 2006.
54. Van Pelt RE, Gozansky WS, Schwartz RS, Kohrt WM. Intravenous estrogens increase insulin clearance and action in postmenopausal women. Am J Physiol Endocrinol Metab 285: E311-E317, 2003.
55. Vehkavaara S, Westerbacka J, Hakala-Ala-Pietila T, Virkamaki A, Hovatta O, Yki-Jarvinen H. Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women. J Clin Endocr Metab 85: 4663-4670, 2000.
56. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effects of the menopause transition on insulin sensitivity, secretion and elimination in nonobese, healthy women. Eur J Clin Invest 23: 466-473, 1993.
57. Wu SI, Chou P, Tsai ST. The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 54: 117-120, 2001.
58. Xu A, Chan KW, Hoo RLC, Wang Y, Tan KCB, Zhang J, Chen B, Lam MC, Tse C, Cooper GJS, Lam KSL. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 280: 18073-18080, 2005.
59. Yki-Jarvinen H. Insulin sensitivity during the menstrual cycle. J Clin Endocr Metab 59: 350-353, 1984.